Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: A systematic review

Carolien M.j. Van Der Linden, Paul A.f. Jansen, René J.e. Grouls, Rob J. Van Marum, Marianne A.j.w. Verberne, Lieke M.a. Aussems, Toine C.g. Egberts, Erik H.m. Korsten

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Represcription of medication that was withdrawn after the occurrence of an adverse drug event (including allergy), is a recognized medication safety issue on a patient level. We performed a systematic review to identify systems (electronic and nonelectronic) that can prevent the represcription of drugs withdrawn because of an adverse drug event and the effects of these systems. The review was performed using PRISMA and Cochrane guidelines. PubMed and Embase were searched for articles describing systems that can prevent represcription of drugs that had been withdrawn for causing an adverse drug event. Information on the characteristics of the studies, systems, and if present results achieved with such systems, was extracted. The results showed that of 6793 articles screened, 137 full-text articles were assessed for eligibility. A total of 45 studies describing 33 systems (28 electronic) were included. The five nonelectronic systems used allergy bracelets or allergy labels on hospital medical records or on drug orders. Systems differed in the way adverse drug events were documented and how users were alerted to drug represcription. Most systems functioned within a specific healthcare setting. Of 12 studies that compared pre- and post-intervention periods or wards with and without intervention, 7 showed a reduction in represcription after adverse drug event. In conclusion, several systems have been developed that can prevent the represcription of drugs that elicited an adverse drug event, but the evidence that these systems are effective is limited.

Original languageEnglish
Pages (from-to)73-90
Number of pages18
JournalTherapeutic Advances in Drug Safety
Volume4
Issue number2
DOIs
Publication statusPublished - 1 Jan 2013

Cite this

Van Der Linden, C. M. J., Jansen, P. A. F., Grouls, R. J. E., Van Marum, R. J., Verberne, M. A. J. W., Aussems, L. M. A., ... Korsten, E. H. M. (2013). Systems that prevent unwanted represcription of drugs withdrawn because of adverse drug events: A systematic review. Therapeutic Advances in Drug Safety, 4(2), 73-90. https://doi.org/10.1177/2042098613477125